Tumors, Cappellari (GSK): “The ‘change of direction’ for ovarian cancer continues in the regions”

With the 2023 white paper, “the ‘let’s change course’ project has brought out the voices of women with ovarian cancer to give us the opportunity to identify and respond to their needs. GSK is committed to continuing this journey and this ‘change of direction’ by going to the territory, to the regions, to offer information and support to all women. Campania represents a virtuous example for taking care of women with ovarian cancer”, but the journey continues. Laura Cappellari, Patients Affairs Director of GSK, said this regarding the event ‘Ovarian cancer in Campania: Let’s change course’, organized under the patronage of Acto, the Association against ovarian cancer, and with the sponsor of GSK.